ERBB2 and neoplasm: Cao et al. [68] developed a novel HER2-targeting peptide probe (DOTA-ZC02-ICG) for NIR-II FLI and PET dual-modality tumor imaging, which showed excellent tumor targeting performance and imaging effect.